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Summary  HIV  serological  diagnosis  has  evolved  during  the  last  decade  to  give  rise
to  rapid  testing  using  biological  materials,  such  as  blood  or  oral  mucosal  transudate
(OMT).  However,  blood  collection  is  not  always  welcomed,  justifying  the  evaluation
of  OMT-based  devices.  In  a  cross  sectional  study  carried  out  in  May  2011  aimed  at
evaluating  the  level  of  awareness  about  OMT  based  HIV  tests,  questionnaires  were
administered  to  participants  who  consented  to  take  part  in  the  study.  Eighty-ﬁve
percent  (n  =  1520)  of  participants  reported  a  lack  of  awareness  of  HIV  oral  screening
before  the  study,  and  surprisingly,  no  association  was  found  between  the  awareness
of  participants  and  their  educational  level  (p  =  0.768).  There  was  also  no  associa-
tion  (p  =  0.743)  found  between  having  had  previous  screening  tests  and  awareness
of  oral  testing.  The  percentage  of  participants  who  accepted  the  oral  test  before
being  informed  about  it  was  31.3%  (n  =  1520).  After  sensitization,  76.3%  (n  =  1520)
preferred  oral  screening  for  future  tests  (p  =  0).  These  results  reveal  that  if  the  OMT
based  test  is  affordable,  its  implementation  as  a  screening  tool  in  the  general  popu-
lation  could  greatly  increase  participation  in  screening  campaigns  and  is  welcomed
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by  those  who  want  to  self-test  in  a  non-invasive  way.  This  will  create  a better  estima-
revalence.  Its  use  could  then  have  a signiﬁcant  public  health
n  and  clinical  management.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
ed.
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he  overall  HIV  prevalence  in  Cameroon  was
eported to  be  4.3%  in  2011.  Among  the  various  risk
roups, HIV  prevalence  was  as  follow:  sex  workers,
7%; military  men,  6%;  and  pregnant  women,  7.8%
EDS, 2011)  [1].
During  the  past  decade,  HIV  serological  diagnosis
as evolved  considerably  from  a  1st  to  a  4th  gener-
tion of  tests.  Most  of  the  kits  used  in  serology  are
ased on  HIV  antibody  detection  in  blood  samples.
owever, blood  collection  is  not  always  accepted
y many  populations  for  several  reasons.  A  study
arried  out  by  Gregson  et  al.  [2]  revealed  that  an
rrational  fear  of  Satanism  was  a  common  reason  for
efusing to  provide  Dried  Blood  Spot  (DBS)  samples
n an  epidemiologic  survey  in  Zimbabwe.  Alemnji
t al.  [3]  showed  that  in  some  speciﬁc  groups  of
opulations,  such  as  newborns,  children  and  obese
ndividuals,  blood  sample  collection  has  been  found
o be  particularly  difﬁcult.  Thus,  there  is a  consid-
rable  need  to  use  body  ﬂuids  other  than  blood,
specially if  non-invasive  approaches  are  possible.
his would  be  more  adaptable  for  ﬁeld  use,  espe-
ially  for  high  risk  and  hard-to-reach  populations  or
n resource-constrained  settings,  such  as  the  rural
rea of  the  West  region  of  Cameroon,  as  highlighted
y Constantine  and  Zink  [4]  as  well  as  Keenan  et  al.
5].
Since  2000,  oral  screening  testing  has  become
vailable for  point-of-care  (POC)  HIV  antibody  test-
ng in  many  countries  of  the  world,  leading  to  a
igniﬁcant  increase  in  HIV  screening  participation
t testing  sites,  as  reported  by  Facente  et  al.  [6].
In Cameroon,  studies  have  been  carried  out  by
dembi  et  al.  [7]  and  Nkenfou  et  al.  [8]  to  eval-
ate oral  ﬂuid  test  devices  for  their  potential
se as  rapid  POC  testing.  Moreover,  in  the  West
egion of  Cameroon,  populations  are  still  highly
ttached to  their  culture  and  traditions  and  are
sually  skeptical  with  regard  to  blood  collection.
he implementation  of  HIV  oral  ﬂuid  testing  as
 component  of  HIV  control  initiatives  and  pro-
rams in  Cameroon  offers  many  advantages,  such
s improved  national  coverage,  which  will  increase
he possibility  of  obtaining  real  estimations  of  the
Q
p
ulobal  prevalence.  This,  in  turn,  will  permit  more
dequate  and  targeted  HIV/AIDS  prevention,  treat-
ent and  control  programs.  This  study  aimed  at
valuating the  level  of  awareness  of  the  existence
f an  HIV  oral  ﬂuid  test.  Speciﬁcally,  we  wanted
o know  the  pre-test  levels  of  awareness  and  post-
est acceptability  for  rapid  oral  ﬂuid  HIV  tests  in
 region  reportedly  plagued  by  ‘‘traditional  ritu-
ls and  cultural  believes’’.  We  hypothesized  that
hen populations  are  aware  of  the  oral  test,  they
ill prefer  it  to  the  blood-based  test.
aterials and methods
tudy design and sample population
 survey  study  for  cross-sectional  analysis  was  car-
ied out  in  Dschang,  Cameroon  in  May  2011  to
valuate  the  level  of  awareness  of  rapid  oral  ﬂuid
esting during  a free  screening  campaign  with  par-
icipants attending  voluntary  counseling  and  testing
ervices. This  study  was  carried  out  during  the
nnual  university  games  that  mobilize  students
rom all  of  the  6 state  Universities  of  Cameroon.
uestionnaires  were  then  administered  to  partic-
pants  before  and  after  being  screened  with  the
MT-based  test  (OraQuick  HIV  1/2  Rapid  Antibody
est Orasure  Technologies  Bethlehem,  PA  18015,
SA).
thical considerations
ur  study  received  the  approval  of  the  NEC
National Ethical  Committee,  authorization  n◦
15/CNE/SE/2012)  of  Cameroon.  Participants  gave
heir written  consent  and  were  assured  of  conﬁden-
iality by  the  attribution  of  encoded  identiﬁcation
umbers.uestionnaires  were  administered  to  our  partici-
ants  before  and  after  being  screened  sequentially
sing gold  standard  HIV  tests  with  blood  samples
C.N.  Nkenfou  et  al.
Table  1  Description  of  the  study  population.
Characteristic  Number  (percentage)
Gender
Male  940  (62.0
Female  575  (38.0)
Missing  data  5
Age  group
<20  267  (17.6)
20—29 1036  (68.2)
>29  217  (14.3)
Education  level
Primary  23  (1.5)
Secondary  998  (68.5)
Higher  436  (30.0)
Missing  data  63
Awareness  on  serological  status  of  the  sexual  partner
Yes  552  (38.9)
No  867  (61.1)
Missing  data  101
Knowing  any  HIV  positive  relatives
Yes 618  (40.7)
No  900  (59.3)
Missing  data 2
Having  more  than  one  sexual  partner
Yes 463  (30.9)
No  1033  (69.2)
Missing  data 24
Frequency  of  condom  use
Never  312  (22.0)
Occasionally  455  (32.2)
Always  647  (45.8)
Missing  data  106
Awareness  on  oral  test  before
Yes  226  (14.9)
No  1289  (85.0)
Missing  data  5
Test  preference  before  sensitization
Blood  830  (55.3)
Oral  469  (31.3
None  201  (13.4)
Missing  data  20
Test  preference  after  sensitization
Blood  343  (23.7)
Oral  1102  (76.3)
Missing  data  75
s
a
r
s
a256  
(determine  HIV-1/2  Ag/Ab  combo  rapid  test  and
HIV (1 +  2)  Antibody  (colloidal  gold)  KHB  Shanghai
Kehua Bio-engineering  Co.  Ltd.,  China)  and  OMT-
based tests  (ORAQUICK® Rapid  HIV-1/2  Antibody).
The questionnaires  were  designed  to  collect  data
including:  age,  sex,  educational  level,  knowledge
level of  HIV/AIDS,  sexual  activities,  number  of
HIV tests  that  they  had  received  previously,  and
awareness  of  and  preference  for  HIV  oral  testing.
After receiving  an  identiﬁcation  number,  counselors
assisted the  participants  in  ﬁlling  out  the  question-
naires.
Data and statistical analysis
Analysis  of  the  data  from  the  questionnaires  was
carried  out  using  Microsoft  Excel  2010  and  statis-
tical  software  (stata,  release  13)  [9]. The  level  of
awareness  of  the  study  population  regarding  rapid
oral ﬂuid  testing  and  the  preference  of  this  test
after sensitization  were  captured  as  a  binary  vari-
able equal  to  1  if  the  individual  knew  or  preferred
the oral  test  and  0  if  not.  The  following  parameters
were taken  into  account  during  analysis:  gender,
age group,  educational  level,  risk  behaviors  (num-
ber of  sexual  partners,  frequency  of  condom  usage,
and awareness  of  sexual  partner’s  HIV  sero-status).
A comparison  of  the  awareness  of  the  HIV  oral  test
between  different  groups  was  carried  out  using  the
chi square  test.
Results
During  this  study,  1625  people  were  contacted  and
1520 consented  to  participate.  The  mean  age  (in
years) of the  participants  was  24  ±  6.5,  ranging
from 13  to  49  years.  Over  half  (62%,  n  =  1520  partic-
ipants)  were  male,  30%  (n  = 1520)  attended  higher
school,  and  68.5%  (n  =  1520)  and  1.5%  (n  =  1520)
were from  secondary  and  primary  schools.  Over
half (61.1%)  of  the  participants  were  not  aware
of the  HIV  sero-status  of  their  sexual  partner.  The
overall  characteristics  of  the  study  population  are
presented  in  Table  1. The  risk  behaviors  observed
in this  population  (n  =  1520)  are  as  follows:  61.1%
of the  participants  were  not  aware  of  the  HIV  sero-
status  of  their  partner,  30.9%  had  more  than  one
sexual  partner,  and  22%  and  32.2%  frequently  and
occasionally  used  condom  during  sexual  activities,
respectively.  The  overall  HIV  antibody  positivity  in
the study  population  was  1%  and  was  conﬁrmed  by
the national  HIV  testing  algorithm  of  Cameroon.
As presented  in  Table  1, when  participants  were
asked if  they  knew  about  the  existence  of  HIV  oral
n
(
b
acreening  tests  before  the  current  contact,  data
nalysis  revealed  that  85%  (n  =  1520)  of  participants
eported that  they  had  never  heard  about  HIV  oral
creening  before  and  only  14.9%  (n  =  1520)  were
ware of  the  existence  of  the  oral-based  test.
No association  was  found  between  the  aware-
ess of participants  and  their  educational  level
p =  0.768).  Additionally,  no  association  was  found
etween  been  awareness  of  the  oral  test  and  the
ge of  the  participants  (p  =  0.425).
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Table  2  Factor  associated  to  oral  test  preference
(after  sensitization).
Oral  test  preference
after  sensitization  by
individual
characteristic  (%)
p
Gender
Male  75.8  0.644
Female  75.7
Education  level
Primary  75.0  0.077
Secondary  74.3
Higher  79.9
First  time  to  be  tested
Yes  72.4  0.005
No  78.7
Age  group
<20  70.4  0.028
20—24 77.1
25—29 78.1
>29  83.5
Risky  behavior
Yes 79.7 0.039
No  74.7
Knowing  any  PLWHIVa
Yes 74.6 0.213
No  77.4
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More  than  900  participants  (n  =  916,  60.3%)
dmitted they  had  previously  had  an  HIV  screening
est, but  786  (85.8%,  n  =  916)  of  them  were  unaware
f the  existence  of  an  HIV  oral  screening  test.
mong those  who  admitted  that  this  was  their  ﬁrst
creening  test,  84.5%  (n  = 602)  also  admitted  they
ere unaware  of  the  existence  of  an  HIV  oral-based
est. Thus,  no  association  (p  =  0.743)  was  found
etween participants  who  had  been  tested  previ-
usly and  their  awareness  of  an  existing  HIV  oral
est.
The analyses  showed  that  no  factors  were  associ-
ted with  oral  test  awareness  before  sensitization,
ncluding education  level,  age  group  or  even  num-
er of  prior  HIV  tests.
Before  the  administration  of  the  oral  screening
est, the  participants  were  asked  to  choose
etween a blood  screening  test  and  an  oral  test.  We
ound that  55.3%  (n  =  1520)  preferred  blood-based
creening devices  compared  to  only  31.3%  (n  = 1520)
ho chose  the  oral  ﬂuid  testing  method.  Some  201
articipants  (13.8%)  had  no  preference  and  20  par-
icipants  did  not  answer  the  question  (see  Table  1).
After sensitization  and  administration  of  the  oral
creening  test,  participants  were  asked  again  if
hey would  like  to  be  screened  with  oral  screening
est or  blood  screening  tests  in  the  future.  Two-
hirds (76.3%,  n  =  1520)  stated  a  preference  for  a
uture oral  screening  test  compared  to  only  23.7%
n = 1520)  of  participants  who  preferred  the  blood
est.  A  small  proportion  (5.1%)  of  the  1520  partici-
ants  had  no  preference.  There  was  a  statistically
igniﬁcant difference  for  the  preference  of  the  oral-
ased test  before  compared  to  after  sensitization
p =  0).
After  sensitization,  no  association  was  found
n the  preference  of  oral  test  according  to  gen-
er or  educational  level  (p  =  0.644  and  p  =  0.077,
espectively). An  association  was  found  between
he oral  preference  after  sensitization  and  the  num-
er of  prior  HIV  tests  (p  =  0.005),  and  the  age  group
p =  0.028).  In  fact,  as  the  population  gets  older
hey tend  to  prefer  the  oral  test  when  aware  of  its
xistence.  An  association  was  also  found  between
he preference  for  an  oral  HIV  test  and  risk  behavior
p =  0.039),  see  Table  2.
iscussion
any  rapid  test  assays  have  been  developed  to
nable  HIV  detection  in  as  little  as  20  min  at  the
OC, among  which  the  oral  screening  testing  assay
s probably  the  least  invasive.  This  testing  method
as been  evaluated  in  many  clinical  settings  around
d
w
(
pBold values signify p less than 0.05.
a People living with HIV.
he  world  since  its  approval  by  the  UNAIDS/WHO
n 2005—2006  [10].  Our  study  revealed  that  since
he approval  of  this  oral  test,  many  Cameroonians
re still  not  aware  of  its  existence  (85.3%  of  our
ample population).  Surprisingly,  we  found  no
elation between  the  awareness  of  the  population
bout an  existing  HIV  oral  ﬂuid  testing  method
nd their  level  of  education  or  between  awareness
nd having  had  previous  HIV  screening  tests.  One
xplanation  could  be  the  fact  that  the  oral  testing
ethod is  not  yet  fully  integrated  into  health
nd medical  HIV  care  programs.  On  the  other
and, after  sensitization,  there  was  a  correlation
etween the  oral  test  preferences  of  the  partici-
ants  and  their  age:  the  older  the  participants,  the
igher their  preference  for  oral  testing.  This  could
mply that  as  they  aged,  they  are  more  aware  of
he risks  related  to  blood  testing  or  that  they  still
old a  skeptical  view  of  traditional  rituals  and
ultural  believes  concerning  blood.  The  association
etween  the  age  of  the  participants  and  their  pref-
rence for  an  oral  screening  test  may  be  biased
ue to  the  age  distribution  of  our  study  population,
hich included  many  more  youths  than  adults
a prominent  characteristic  of  the  Cameroonian
opulation).  Although  the  study  took  place  during
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the  university  games,  study  participants  had  a wide
variety of  backgrounds  not  only  university  students
but also  secondary  students,  farmers,  and  workers,
and the  participants  were  13—49  years  old.  The  bias
may only  be  that  those  who  were  not  interested  in
the university  games  could  not  be  assessed  for  their
preferences  or  awareness.  It  is  important  to  note
that this  survey  study  may  be  hampered  by  biases,
as ethically  we  could  not  force  participation.
Before  its  administration,  only  31.3%  of  partici-
pants expressed  a  desire  to  get  tested  using  an  oral
device.  This  trend  was  reversed  after  ‘‘lectures’’
on the  advantages  and  disadvantages  of  oral  test-
ing, and  thus,  76.3%  of  the  sample  population
admitted that  they  would  prefer  oral  screening  test
devices for  future  testing.  These  ﬁndings  reveal
how successful  the  acceptance  of  this  screening
device could  be  in  the  populations,  which  might
lead to  increased  participation  in  screening,  poten-
tially leading  to  a  better  estimation  of  both  the
national and  global  prevalence.
The OMT  kit  offers  many  advantages,  includ-
ing: being  non-invasive,  not  needing  a  well-trained
phlebotomist, being  less  painful  and  uncomfort-
able, not  having  a  risk  of  blood  exposure  for  staff
and personnel  as  well  as  the  participants,  hav-
ing easy  storage  conditions  and  having  no  need
for complex  materials  or  a  power  supply  for
storage.
In countries  where  populations  are  already
aware of  the  existence  of  oral  ﬂuid  testing,  Delaney
et al.  [11]  observed  that  the  preference  and  accept-
ability  of  this  assay  has  increased  as  well  as  the
number of  people  who  are  testing  and  receiving
their results.
Some  ﬁeld  evaluation  studies  of the  ORAQUICK®
HIV-1/2  Ab  Rapid  Test  carried  out  by  Nkenfou  et  al.
[8]  highlighted  the  fact  that  this  test  presents
comparable speciﬁcity  and  sensitivity  with  blood-
based  tests  as  well  as  many  of  the  advantages
listed above.  This  means  that  it  is  highly  suit-
able to  be  implemented  in  medical  outreach  in
Cameroon,  especially  in  populations  with  strong
cultural  believes  and  taboos  about  blood-related
practices. This  also  suggests  that,  if  included  in
the Cameroonian  National  Program  for  HIV  testing,
it could  greatly  impact  HIV  control  initiatives  and
programs.  There  is  a  compelling  reason  to  educate
populations about  the  option  of  oral  HIV  testing  and
to make  sure  their  tests  are  fully  incorporated  in
HIV screening  campaigns.
However,  this  screening  method  does  have  some
limitations. Ndembi  et  al.  [7]  demonstrated  that
some oral  ﬂuid  based  kits  fail  to  detect  certain  HIV
subtypes  (notably  HIV-1  group  O  and  HIV-1  group
N). This  can  be  a  real  disadvantage,  especially  in
C
TC.N.  Nkenfou  et  al.
ameroon,  which  is  known  to  harbor  many  different
IV-1 subtypes,  as  highlighted  in  the  HIV  Sequence
ompendium [12]. To  overcome  this  disadvantage,
e suggest  that  the  manufacturer  expand  the
train-speciﬁc  antigens  on  the  test  strip.
One limiting  factor  to  the  implementation  of  the
raquick  test  could  be  its  cost,  which  is  very  expen-
ive (4.00—12.00  US$  or  1600—4800  CFA  francs)
ompared to  the  reference  standard  tests  (1.5—2
S$ or  600—800  CFA  francs).  Additionally,  the  occur-
ence of  false  negative  results  may  be  another
hortcoming of  the  oraquick  test.  False  negative
esults can  occur  with  ORAQUICK® when  used  to
creen asymptomatic  patients  with  unknown  HIV
tatus, particularly  those  with  early  HIV  infection
nd in  a  population  characterized  by  a relatively
ow HIV/AIDS  prevalence  [11,13,14]. However,  as
ecognized  by  the  UNAIDS/WHO  [10]  since  1998,  HIV
erodiagnosis,  particularly  in  resource  limited  sett-
ngs, should  not  be  hindered  by  factors  such  as  the
eed for  trained  personnel,  the  high  cost  of  equip-
ent and  reagents,  and  the  lack  of  a power  supply
nd laboratory  infrastructures.  The  performance  of
raquick, as  demonstrated  by  Alemnji  et  al.  [3]  and
kenfou et  al.  [8]  in  populations  with  different  viral
iversities,  such  as  Cameroon,  makes  it a reliable
ool for  HIV  testing.
onclusion
hen  sensitized  about  the  existence  of an  oral
ased test,  the  population  preferred  it  for  their
uture  HIV  screening.  The  use  of  an  OMT-based  test
or HIV  testing  could  have  a signiﬁcant  public  health
mpact  on  HIV  prevention  and  clinical  management
n light  of  the  ﬁnding  that  76.3%  of  participants  pre-
erred the  OMT-based  test  for  future  screening.  This
emonstrates  that  if  provided  at  the  same  cost  as
ther HIV  blood  based  tests,  the  implementation
f OMT  devices  for  HIV  testing  will  be  successful  in
oth Cameroon  and  other  populations.  The  manu-
acturer  should  modify  their  test  device  to  reduce
he cost  per  patient.  Decision  makers  should  take
he lead  to  include  oral  testing  in  the  national  algo-
ithm.
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